Active, Not Recruiting
A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP)
NCT05031780
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
- Locations
-
- University of California San Diego La Jolla, California, United States
- UCLA Health Los Angeles, California, United States
- Children's Hospital Oakland Oakland, California, United States
- University of Connecticut Health Center Farmington, Connecticut, United States